Development of lecithinized superoxide dismutase

Tohru Mizushima

Research output: Contribution to journalArticle

Abstract

Idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) are considered to involve lung injury induced by reactive oxygen species (ROS), in particular superoxide anion. The enzyme, superoxide dismutase (SOD) catalyses the dismutation of superoxide anion to hydrogen peroxide. Lecithinized SOD (PC-SOD) has overcome a number of previous clinical limitations of SOD, including low tissue affinity and low stability in plasma. Recent animal studies suggest that PC-SOD is effective for the treatment of IPF and COPD. We are now performing a clinical study of PC-SOD for IPF patients.

Original languageEnglish
Pages (from-to)1094-1103
Number of pages10
JournalJapanese Journal of Chest Diseases
Volume72
Issue number10
Publication statusPublished - 2013

Fingerprint

Superoxide Dismutase
Idiopathic Pulmonary Fibrosis
Superoxides
Chronic Obstructive Pulmonary Disease
Lung Injury
Hydrogen Peroxide
Reactive Oxygen Species
lecithinized superoxide dismutase
Enzymes
Therapeutics

Keywords

  • Chronic obstructive pulmonary disease
  • Idiopathic pulmonary fibrosis
  • Lecithinized SOD
  • Reactive oxygen species
  • Superoxide dismutase

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Development of lecithinized superoxide dismutase. / Mizushima, Tohru.

In: Japanese Journal of Chest Diseases, Vol. 72, No. 10, 2013, p. 1094-1103.

Research output: Contribution to journalArticle

Mizushima, T 2013, 'Development of lecithinized superoxide dismutase', Japanese Journal of Chest Diseases, vol. 72, no. 10, pp. 1094-1103.
Mizushima, Tohru. / Development of lecithinized superoxide dismutase. In: Japanese Journal of Chest Diseases. 2013 ; Vol. 72, No. 10. pp. 1094-1103.
@article{d4aea4fe8666457ba2bc8d4ef25890ab,
title = "Development of lecithinized superoxide dismutase",
abstract = "Idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) are considered to involve lung injury induced by reactive oxygen species (ROS), in particular superoxide anion. The enzyme, superoxide dismutase (SOD) catalyses the dismutation of superoxide anion to hydrogen peroxide. Lecithinized SOD (PC-SOD) has overcome a number of previous clinical limitations of SOD, including low tissue affinity and low stability in plasma. Recent animal studies suggest that PC-SOD is effective for the treatment of IPF and COPD. We are now performing a clinical study of PC-SOD for IPF patients.",
keywords = "Chronic obstructive pulmonary disease, Idiopathic pulmonary fibrosis, Lecithinized SOD, Reactive oxygen species, Superoxide dismutase",
author = "Tohru Mizushima",
year = "2013",
language = "English",
volume = "72",
pages = "1094--1103",
journal = "Japanese Journal of Chest Diseases",
issn = "0385-3667",
publisher = "Kokuseido Publishing Co. Ltd",
number = "10",

}

TY - JOUR

T1 - Development of lecithinized superoxide dismutase

AU - Mizushima, Tohru

PY - 2013

Y1 - 2013

N2 - Idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) are considered to involve lung injury induced by reactive oxygen species (ROS), in particular superoxide anion. The enzyme, superoxide dismutase (SOD) catalyses the dismutation of superoxide anion to hydrogen peroxide. Lecithinized SOD (PC-SOD) has overcome a number of previous clinical limitations of SOD, including low tissue affinity and low stability in plasma. Recent animal studies suggest that PC-SOD is effective for the treatment of IPF and COPD. We are now performing a clinical study of PC-SOD for IPF patients.

AB - Idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) are considered to involve lung injury induced by reactive oxygen species (ROS), in particular superoxide anion. The enzyme, superoxide dismutase (SOD) catalyses the dismutation of superoxide anion to hydrogen peroxide. Lecithinized SOD (PC-SOD) has overcome a number of previous clinical limitations of SOD, including low tissue affinity and low stability in plasma. Recent animal studies suggest that PC-SOD is effective for the treatment of IPF and COPD. We are now performing a clinical study of PC-SOD for IPF patients.

KW - Chronic obstructive pulmonary disease

KW - Idiopathic pulmonary fibrosis

KW - Lecithinized SOD

KW - Reactive oxygen species

KW - Superoxide dismutase

UR - http://www.scopus.com/inward/record.url?scp=84886491336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886491336&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84886491336

VL - 72

SP - 1094

EP - 1103

JO - Japanese Journal of Chest Diseases

JF - Japanese Journal of Chest Diseases

SN - 0385-3667

IS - 10

ER -